Capital World Investors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-635,000
Closed -$66.3M 560
2017
Q4
$66.3M Hold
635,000
0.01% 328
2017
Q3
$92.6M Hold
635,000
0.02% 300
2017
Q2
$82.5M Sell
635,000
-65,000
-9% -$7.96M 0.02% 298
2017
Q1
$87.1M Hold
700,000
0.02% 299
2016
Q4
$81M Hold
700,000
0.02% 292
2016
Q3
$73.2M Buy
+700,000
New +$75.8M 0.02% 303
2015
Q1
Sell
-760,000
Closed -$85M 559
2014
Q4
$85M Hold
760,000
0.02% 313
2014
Q3
$72M Hold
760,000
0.02% 336
2014
Q2
$65.3M Hold
760,000
0.02% 342
2014
Q1
$53M Sell
760,000
-640,000
-46% -$50.7M 0.02% 348
2013
Q4
$118M Sell
1,400,000
-294,000
-17% -$23.3M 0.03% 281
2013
Q3
$130M Sell
1,694,000
-5,264,000
-76% -$369M 0.04% 271
2013
Q2
$407M Buy
+6,958,000
New +$419M 0.13% 171

Other funds holding CELG

Capital World Investors's CELG Position: Q1 2018 in Review

Capital World Investors sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 635,000 shares — an estimated $66.3M sold.

Capital World Investors first reported a position in CELG in Q2 2013 and held it in 13 quarters. The position peaked at $407M in Q2 2013. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Capital World Investors reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Capital World Investors sold 635,000 Celgene Corp shares in Q1 2018, an estimated $66.3M.
  • Capital World Investors first reported a position in Celgene Corp in Q2 2013 and held it in 13 quarters.
  • Capital World Investors's Celgene Corp position peaked at $407M in Q2 2013.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Capital World Investors's 13F filing for Q1 2018, filed 15 May 2018.